Essential Drugs Monitor No. 031 (2002)
(2002; 72 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentEssential Drugs Monitor
Open this folder and view contentsEditorial
Open this folder and view contentsConflict of Interest
View the documentLetter from the Editor
Close this folderNews Desk
View the documentCalls for stronger consumer voice at conference on medicines and media
View the documentRegulating drug promotion in Europe: meeting debates way forward
View the documentAlliance protects rights to genetic resources
View the documentRussia acts to curb counterfeits
View the documentISDB defines genuinely innovative drugs
View the documentDelhi: commitment to continuing pharmacy education
View the documentDrug companies employ many more staff for marketing than R&D
View the documentWorld Consumer Rights Day
View the documentUS groups criticise magazine's special issue on health
View the documentAustralia reports on a decade of quality use
View the documentAdverse reactions to drugs increase
View the documentLearning how to get RUD messages across to communities
View the documentUN initiative evaluates HIV medicines
View the documentConference promotes regional collaboration in SAARC countries
View the documentTackling antimicrobial resistance
View the documentStudy on research and development costs questioned
View the documentWHO at work in Afghanistan
View the documentNetscan, Meetings & Courses
Open this folder and view contentsResearch
Open this folder and view contentsDrug Promotion
Open this folder and view contentsNational Drug Policy
Open this folder and view contentsAccess
Open this folder and view contentsRational Use
Open this folder and view contentsAccess
 

Calls for stronger consumer voice at conference on medicines and media

DAVID FINER*

 

* David Finer is a medical writer.


THE role and particular responsibilities of medical journalists came under scrutiny at a Conference entitled Medicines-People-Media, held in Stockholm on 16 October 2001. With the Swedish Medicines Agency as main organizer and Health Minister, Lars Engqvist, as opening speaker, 150 people heard presentations and discussions ranging over some of the contentious issues surrounding media reporting on medicines.

Keynote speaker was David Gilbert, Head of the Patient and Public Involvement Commission for Health Improvement in the UK. He made the case that the media essentially fail to represent the consumer interest, actively disregarding vital health aspects, such as preventive and palliative medicine. Media messages are too often polarised in positive (hope) and negative (fear) directions. As the power of both media and pharmaceutical industries increase, so too do the commercial pressures on journalism, he said.

Speaking about the research process, Gilbert argued that once again consumer influence is rare, with Alzheimer's research an exception. He told the Conference that initial scientific scepticism has given way to enthusiasm for "real-life" patient input to the research process, generating new angles and safeguarding the relevance of the research. He urged that this experience should serve as an example for similar initiatives.

Another speaker addressed the issue of "critical medical journalism", saying that it is about refusing to become a passive megaphone, and about helping the audience separate fact from fantasy - reporting accurately about things of relevance. The representative of the WHO Collaborating Centre for International Drug Monitoring in Uppsala, Sweden, focused on reporting drug safety issues. He spoke about the meaning of the Erice Declaration for drug safety (see Monitor No. 25/26, page 26, for further details). He reminded the audience of the Declaration's preamble which says that monitoring, evaluating and communicating drug safety must be governed by high scientific, ethical and professional standards as well as a moral code.

Media fail the consumer

Taking up a theme in the keynote speech, the Collaborating Centre representative summarised some current media failings, which he said include too little empowerment of both health care staff and patients as information receivers and too little analysis of their needs. In conclusion, he raised the important but frequently overlooked question of how to inform the vast number of people in high- and low-income countries who have literacy problems.

The day resulted in a number of proposals, including the need to formulate special ethical rules for medical journalists, and for them to assume greater responsibility for potential consequences of their reporting. Participants also called for active exploration of new forms for consumer participation and influence over media content.

to previous section to next section
 

Last updated: April 24, 2012